Follow us on Facebook
Follow us on Facebook
Follow us on Twitter


Showing 2 articles from August 3, 2016.


Study Bodes Well For Biosimilars But Highlights Need For More Research

In the absence of generic alternatives to these pricey treatments, biosimilar drugs hold great promise for U.S. patients and their wallets.



Medicare's Readmission Penalties Hit New High

Medicare said the penalties are expected to total $528 million, about $108 million more than last year, because of changes in how readmissions are measured.

Powered by Bondware
News Publishing Software

The browser you are using is outdated!

You may not be getting all you can out of your browsing experience
and may be open to security risks!

Consider upgrading to the latest version of your browser or choose on below: